Toggle light / dark theme

The U.S Food and Drug Administration (FDA) has approved a new drug combination for men with metastatic, castration-resistant prostate cancer (mCRPC) and certain DNA repair gene mutations, widening treatment options for this large patient population.

The androgen-receptor inhibitor enzalutamide plus the PARP inhibitor talazoparib can now be used as first-line treatment for mCRPC patients who have homologous recombination repair (HRR) gene alterations.

#MetastaticProstateCancer.

A new combination therapy for for metastatic prostate cancer that includes an already approved breast cancer drug was just approved by the FDA last month on June 20. It has many excited.


Imagine an iPad that’s more than just an iPad—with a surface that can morph and deform, allowing you to draw 3D designs, create haiku that jump out from the screen and even hold your partner’s hand from an ocean away.

That’s the vision of a team of engineers from the University of Colorado Boulder. In a new study, they’ve created a one-of-a-kind shape-shifting display that fits on a card table. The device is made from a 10-by-10 grid of soft robotic “muscles” that can sense outside pressure and pop up to create patterns. It’s precise enough to generate scrolling text and fast enough to shake a chemistry beaker filled with fluid.

It may also deliver something even rarer: the sense of touch in a digital age.

ATLANTA (AP) — A new reactor at a nuclear power plant in Georgia has entered commercial operation, becoming the first new American reactor built from scratch in decades.

Georgia Power Co. announced Monday that Unit 3 at Plant Vogtle, southeast of Augusta, has completed testing and is now sending power to the grid reliably.

At its full output of 1,100 megawatts of electricity, Unit 3 can power 500,000 homes and businesses. Utilities in Georgia, Florida and Alabama are receiving the electricity.

Electric vehicle manufacturer Tesla is the frequent subject of rumors and speculation, all of which must be taken with a grain of salt. But if the newest batch of rumors is to be believed, Tesla is currently looking into an “extreme fast charging” technology developed by Israeli startup StoreDot, per Inside EVs.

The news comes via an article in USA Today that, as Inside EVs noted, “doesn’t cite any sources.” The USA Today article in question was written by a contributor and contained a disclaimer at the bottom reading, “Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of this content.”

If the report is to be believed, Tesla’s interest in StoreDot could mean shorter charging times for Teslas, as the company claims to have developed batteries that can charge 100 miles of driving range in just five minutes, per Inside EVs.

Rothschild calls this “living tech,” which starts with the power of the cell. Microscopic organisms will produce silk, wool, latex, silica, and other materials. We’ll send digital information to biofactories on Mars through DNA sequences. We’ll generate and store power using living organisms. Rothschild said one of her students incorporated silver atoms into plant DNA to make an electrical wire.

“Once you think of life as technology,” Rothschild said, “you’ve got the solution.”

Humans have many practical reasons to become multi-planetary. But the mission shouldn’t represent merely a life insurance policy for the species. We’re still explorers and visionaries, so let’s harness that ambition for an aspirational purpose.

Arms reduction is a noble goal, but it’s not one being pursued by some of the worst regimes in the world. The late George Shultz, former secretary of state for Ronald Reagan and a Cold Warrior, once advised against proliferating nuclear weapons. He quipped that “proliferation begets proliferation,” which the arms control lobby has used for decades to prevent the U.S. government from developing nukes.